Pillstats
Rx only · Tablet · Oral

Febuxostat

Brands: Uloric · Febuxostat

14 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US25 NDCs
14 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)73689
US makers14 labelers
Packages66
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 14 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.503$1.01$1.51$2.01Dec 2025Apr 2026Jul 2026
$1.731
Latest avg · Jul 22, 2026
-1%
Since Dec 17, 2025
14
Active US suppliers
36%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.1K4.3K6.4K8.6K2025 Q12025 Q22025 Q32025 Q42026 Q1
5.6K
Rx · 2026 Q1
256K
Units dispensed
-25%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it14 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Lifesciences Limitedunknown12SUPPLYING
Viona Pharmaceuticals Incunknown12SUPPLYING
Takeda Pharmaceuticals America, Inc.unknown8SUPPLYING
Dr.Reddy's laboratories Limitedunknown8SUPPLYING
Aurobindo Pharma Limitedunknown7SUPPLYING
Solco Healthcare US, LLCunknown6SUPPLYING
HEC Pharm USA Inc.unknown2SUPPLYING
Lannett Company, Inc.unknown2SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown2SUPPLYING
Golden State Medical Supply, Inc.unknown2SUPPLYING
Tris Pharma Incunknown2SUPPLYING
Aphena Pharma Solutions - Tennessee, LLCunknown1SUPPLYING
NuCare Pharmaceuticals, Inc.unknown1SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.